01—Abstract
Summary
Summary of the 8-K filed September 25, 2025. Cited figures are marked; the original filing is the authoritative source.
Rocket Lab Corporation has announced a significant acquisition, entering into a Stock Purchase Agreement to acquire all outstanding ordinary shares of Mynaric AG, a German-based company.
This strategic move is valued at an aggregate of $75 milliona, with the consideration payable in either cash or Rocket Lab's common stock at the company's discretion. The deal also includes potential post-closing earnout payments of up to $75 million, contingent on Mynaric's revenue performance in 2025, 2026, and 2027, also payable in cash or stock. The acquisition, if completed, represents a substantial expansion for Rocket Lab, integrating Mynaric's business into its operations.
The consideration for the transaction, including any stock issued, will be made under exemptions from registration requirements, specifically Section 4(a)(2) of the Securities Act of 1933. Rocket Lab has committed to filing a resale registration statement for any shares issued in the transaction within 30 days post-closing, providing liquidity assurances for those receiving stock. The transaction is subject to customary closing conditions and regulatory approval from the German Ministry of Foreign Affairs.
02—Key points
Key Highlights
- Rocket Lab enters agreement to acquire Mynaric AG for $75 million, with payment in cash or Rocket Lab common stock.
- Potential for up to $75 million in post-closing earnout payments based on Mynaric's revenue targets for 2025-2027.
- Earnout payments can also be settled in cash or Rocket Lab common stock.
- Acquisition consideration issued under an exemption from SEC registration requirements (Section 4(a)(2)).
- Rocket Lab to file a resale registration statement for issued stock within 30 days post-closing.
- Transaction is subject to regulatory approval from the German Ministry of Foreign Affairs.
- The acquisition is structured with customary representations, warranties, and closing conditions.
03—Questions
Frequently Asked Questions
What is Rocket Lab acquiring and for how much?
Rocket Lab is acquiring all of the issued and outstanding ordinary shares of Mynaric AG, a German company. The base purchase price is $75 million, which can be paid in cash or Rocket Lab's common stock.
Are there any additional payments beyond the initial $75 million?
Yes, there is a potential for up to $75 million in additional earnout payments. These payments are contingent on Mynaric's revenue performance in 2025, 2026, and 2027, and can be settled in cash or Rocket Lab's common stock.
Will the stock issued as part of this acquisition be immediately tradable?
The shares issued as consideration will be made under an exemption from registration. However, Rocket Lab has agreed to file a resale registration statement within 30 days after the closing date, which should allow for their resale in the public market, subject to customary exceptions.
What are the conditions for the deal to close?
The transaction is subject to customary closing conditions, including regulatory approval from the German Ministry of Foreign Affairs, and the satisfaction of other conditions outlined in the Stock Purchase Agreement.
04—Continue